Phase I Trial of Zoledronic Acid plus Imatinib Mesylate (Gleevec) in Patients With Bone Metastases
AuthID
P-003-959
P-003-959
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service